1. Home
  2. XOMAP vs INGN Comparison

XOMAP vs INGN Comparison

Compare XOMAP & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAP
  • INGN
  • Stock Information
  • Founded
  • XOMAP N/A
  • INGN 2001
  • Country
  • XOMAP United States
  • INGN United States
  • Employees
  • XOMAP 13
  • INGN 766
  • Industry
  • XOMAP Biotechnology: Pharmaceutical Preparations
  • INGN Industrial Specialties
  • Sector
  • XOMAP Health Care
  • INGN Health Care
  • Exchange
  • XOMAP Nasdaq
  • INGN Nasdaq
  • Market Cap
  • XOMAP N/A
  • INGN 195.2M
  • IPO Year
  • XOMAP N/A
  • INGN 2014
  • Fundamental
  • Price
  • XOMAP $25.90
  • INGN $6.55
  • Analyst Decision
  • XOMAP
  • INGN Strong Buy
  • Analyst Count
  • XOMAP 0
  • INGN 3
  • Target Price
  • XOMAP N/A
  • INGN $11.00
  • AVG Volume (30 Days)
  • XOMAP N/A
  • INGN 203.3K
  • Earning Date
  • XOMAP N/A
  • INGN 08-05-2025
  • Dividend Yield
  • XOMAP N/A
  • INGN N/A
  • EPS Growth
  • XOMAP N/A
  • INGN N/A
  • EPS
  • XOMAP N/A
  • INGN N/A
  • Revenue
  • XOMAP N/A
  • INGN $339,960,000.00
  • Revenue This Year
  • XOMAP N/A
  • INGN $7.47
  • Revenue Next Year
  • XOMAP N/A
  • INGN $6.22
  • P/E Ratio
  • XOMAP N/A
  • INGN N/A
  • Revenue Growth
  • XOMAP N/A
  • INGN 5.73
  • 52 Week Low
  • XOMAP N/A
  • INGN $5.70
  • 52 Week High
  • XOMAP N/A
  • INGN $13.33
  • Technical
  • Relative Strength Index (RSI)
  • XOMAP 53.73
  • INGN 41.45
  • Support Level
  • XOMAP $25.64
  • INGN $7.20
  • Resistance Level
  • XOMAP $26.05
  • INGN $7.61
  • Average True Range (ATR)
  • XOMAP 0.11
  • INGN 0.30
  • MACD
  • XOMAP 0.00
  • INGN -0.07
  • Stochastic Oscillator
  • XOMAP 80.00
  • INGN 0.93

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About INGN Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.

Share on Social Networks: